English Overview
The discussion will cover the safety and efficacy of biosimilar insulins, when it is appropriate to add a rapid acting insulin to intensify therapy in Type 2 Diabetes patients and basics of basal-bolus therapy.
This webinar is for Endocrinologists, Internal Medicine, GP, Family Medicine, Diabetologists
This Activity for
- Resident / Fellow
- Physician
What I will learn?
By the end of the course, you should be able to:
●Understand the safety and efficacy of biosimilar insulin
●Understand when insulin intensification is required in a T2DM patient
●Understand the role of rapid acting insulin in intensification
●Understand basal-bolus therapy
●Understand the safety and efficacy of biosimilar insulin
●Understand when insulin intensification is required in a T2DM patient
●Understand the role of rapid acting insulin in intensification
●Understand basal-bolus therapy
Speakers 1 Distinguished Speakers
Additional items to the activity
| Optional Details | Type | Fee |
|---|---|---|
|
Understanding Biosimilar Insulin and the Role of Rapid Acting Insulin in Intensification Certificate
Accreditation |
Certificate | Free |
VAT 15% Included
